Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Stocks spin their wheels

Stocks spin their wheels - Hot Wheels in the case of Mattel - in the absence of any major economic news.

Blue-chips are sleep-walking their way to the end of a largely satisfactory week.

The Nasdaq Composite was declining to join the party, down five points at 4,865 in lunchtime trading, but the S&P 500 was up just over one point at 2,025 while the trusty old Dow was up 19 at 17,160.

Toys maker Mattel (NASDAQ:MAT) made a surprise appearance in the vanguard of advancing blue-chips, dragging rival Hasbro (NYSE:HAS) – up 2.9% - along with it.

The Barbie doll and Hot Wheels maker missed its earnings estimates in results published after the bell last night, but investors seem not to be in a mood to throw their toys out of the pram, with the shares up 5.7% at US$23.81.

Satellite navigation device maker Garmin (NASDAQ:GRMN) was in hot pursuit of the Hot Wheels firm with a rise of 4.1% to US$33.63, having taken a shellacking earlier yesterday after lowering earnings guidance.

Another stock that took a belting yesterday was hard disk maker Seagate Technology (NASDAQ:STX) after a disappointing trading update, but unlike Garmin, there was no recovery for it today, and it has shed US42.62 to trade at US$48.82.

Investors were tucking into Yum Brands (NYSE:YUM) after the fast food company appointed activist investor Keith Meister to its board.

The move sparked speculation that the company will spin off its China business.

Radius Health (NASDAQ:RDUS) was wanted after, as reported on our sister site in the UK yesterday, talk that Irish pharma giant Shire (LON:SHP) is lining up a bid for the US firm.

Shire is rumored to have appointed advisers to work on a potential US$90 per share bid for Radius, which is developing therapeutics for patients with osteoporosis and other serious endocrine-mediated diseases.

A Shire spokesperson said: "We don't comment on rumor/speculation."

Proactive Investors also called Radius, but at the time of going to press no-one was available to comment.

Radius is thought to be among alternative acquisition candidates that Shire may target if it fails in its US$30bn bid for US rival Baxalta.

General Electric (NYSE:GE) was up 3.2% at US$28.89 after a solid performance in what chief executive and chairman Jeff Immelt said was “a volatile environment” in the third quarter.

Underlying earnings per share, at 29 cents, were better than the figure of 25 cents analysts had penciled in for the industrial giant.

Third quarter results from technology firm Honeywell (NYSE:HON) were a mixed bag, with earnings ahead of Wall Street’s expectations and sales below them.

The maker of aviation components and control systems’ earnings per share of US$1.60 topped the consensus forecast of US$1.55, but revenue of US$9.61bn was down 5% year-on-year and less than the US$9.85bn analysts had predicted.

The shares were on offer at US$9.92, down US$2.50.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK